It has various regulatory biological functions in the neuroimmuno-endocrine system and influences sleepwake cycle, circadian rhythms, tumour inhibition and immune function. 7 Melatonin also plays a neuroprotective role in many CNS disorders, such as Parkinson's disease, Alzheimer's disease, and ischaemic brain injury. 8, 9 Emerging evidence suggested that melatonin could influence the proliferation and differentiation of NSCs. A comprehensive understanding of the effects of melatonin on NSCs may provide valuable insight on developing new therapeutic approaches.
In this article, we review current literatures on the regulatory effects of melatonin on NSCs and discuss its therapeutic potential as a neuroprotective agent in different pathophysiological context. Nevertheless, the downstream molecular mechanism linking these regulatory factors to phenotypic changes in NSCs remains unclear.
| BIOLOGICAL CHARACTERISTICS OF NEURAL STEM CELLS
Understanding these signalling events may contribute to the development of new therapy against diseases related to neuronal death.
| BIOLOGICAL EFFECTS OF MELATONIN ON NEURAL STEM CELLS
The proliferation and differentiation of NSCs are dynamically regulated by the humoral and adhesive factors from the extracellular environment. 14 An increasing number of studies suggested that melatonin is a crucial regulator of precursor cell commitment and differentiation.
In this section, we will summarize the existing evidence on the association between melatonin and NSCs. 
| Expression of melatonin receptor in the CNS

| Effects of melatonin on proliferation and differentiation of NSCs
Melatonin plays a significant role in cell fate specification during neural commitment. More importantly, melatonin significantly increased chromatin remodelling and gene transcription associated with histone H3 acetylation.
As the melatonin MT2 receptor was not present in C17.2 NSCs cells, the MT1 receptor was considered to mediate these biological effects.
| Role of melatonin in neurogenesis
Melatonin promoted the survival of new neurons derived from neural precursor cells in adult hippocampus both in vitro and in vivo.
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Melatonin receptors were involved in these effects as it was blocked by luzindole. In addition, melatonin did not affect neuronal and glial cell maturation and precursor cell proliferation in vivo. These results 
| PROTECTIVE EFFECTS OF MELATONIN ON NSCS IN CNS DISEASES
The promoting effects of melatonin on the proliferation and neuronal differentiation of NSCs make it a potential adjuvant with NSC replacement for the treatment of neural diseases, such as cerebral infarction and neurodegenerative diseases.
| Melatonin and NSCs in Parkinson's disease
Parkinson's disease is hallmarked by the depletion of dopaminergic neurons in the substantia nigra. Kong and colleagues demonstrated that melatonin promoted the viability of NSCs, in which melatonin upregulated the expression of dopaminergic neurons tyroxine hydroxylase and downregulated the astrocytes maker glial fibrillary acidic protein.
Melatonin also increased the production of neurotropic factors in the NSCs in vitro. 27 Moreover, low physiological concentrations of melatonin induced glial cell-line derived neurotrophic factor mRNA expression in NSCs, which promoted the survival of dopaminergic neurons. 16 Sharma and colleagues 28 showed that apomorphine-induced behavioural changes were significantly reduced in striatum-lesioned animals treated by NSC transplantation, melatonin or the combined regimen. Importantly, these treatments protected tyrosine hydroxylase immunoreactivity in the striatum and substantia nigra of lesioned animals compared with untreated controls. Taken together, melatonin in combination with NSC transplantation might be used as a therapeutic approach in Parkinson's disease.
| Melatonin and NSCs in spinal cord injury
Melatonin plus exercise significantly improved the hindlimb function and promoted the proliferation of endogenous NSCs after spinal cord injury. Furthermore, the combined therapy reduced the size of the spinal lesion through increasing the density of dendritic spines and axons. These findings showed that melatonin in combination with exercise significantly promoted endogenous NSC proliferation in spinal cord injury. 29 In another study, melatonin stimulated MT1, which subsequently increased the survival of bovine amniotic epithelial cells and promoted their differentiation into neural cells. Importantly, these cells colonized into injured spinal cord, suggesting their participation in tissue repair. 
| Melatonin and NSCs in neural tube defects associated with diabetic pregnancy
Diabetic pregnancy is associated with neural tube defects in offspring.
In diabetic pregnant mice, intraperitoneal injection of melatonin at the dose of 10 mg/kg per day from embryonic day (E) 0.5 to E11.5 decreased neural tube defects, especially exencephaly, in embryos.
Mechanistically, melatonin stimulated NSC proliferation and decreased apoptosis under hyperglycaemic condition. The mitotic effect of melatonin was mediated through the ERK pathway. 
| CONCLUSION AND FUTURE PERSPECTIVES
Increasing studies have addressed the roles of melatonin on NSCs and highlighted its multiple protective roles in NSCs through promoting cellular survival, proliferation and neural differentiation. Functionally, melatonin prevents neural cells from potentially harmful insults such as hypoxia, inflammation and excessive glucocorticoids. These enable melatonin to be used as an adjunct for NSC grafting and facilitate neural differentiation as appropriate. Further investigations are required to elucidate the currently unknown molecular mechanisms in order to
provide a more precise picture of the regulatory networks ( Figure 1 ).
Hopefully, this will lead to discovery of potential therapeutic targets.
ACKNOWLEDGEMENT
This work was supported by grant from the National Natural Science
Foundation of China (NSFC) (grant number: 81401847).
